◆ 会议时间：2025年6月18-21日
◆ 会议地点：意大利 罗马

◆ 会议简介：

2025年第14届国际皮肤病学大会(ICD2025)将于2025年6月18-21日在意大利罗马举行，会议由国际皮肤科学会(ISD)主办。

国际皮肤科学会(ISD)由Drs Aldo Castellani和Frederick Reiss于1959年发起成立，学会原名为国际热带皮肤病学会，1992年更名为国际皮肤病学、热带、地理和生态学会，1999年更为现名。国际皮肤科学会(ISD)的宗旨是：促进和支持科学研究，促进不同国家的专业人士皮肤病学的各个领域，特别是热带、地理和生态方面的相互了解和合作；在国际上促进与上述皮肤病学领域有关的思想交流，与皮肤病学教育和发展相关的基金会、机构、组织和学会合作；鼓励对皮肤和性传播感染的地理生态进学行调查研究，并举办与这些主题相关的区域会议和研究生课程；根据现有资料，出版官方期刊和其他出版物；与世界卫生组织和其他有关机构建立关系；定期举行国际大会，至少每五年举行一次（未经许可，禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)

ICD 2025 - XIV International Congress of Dermatology
Date: 18-21 June 2025
Venue: Rome Convention Center “La Nuvola”, Rome, Italy

Theme: The Roads of Dermatology

Organized by: International Society of Dermatology (ISD)

摘要征文投稿：

Submission Opening ： 15 February 2024

Submission Closing： DEADLINE EXTENDED 29 October 2024

点此提交摘要>>>Submit Abstract>>>

• ABSTRACT GUIDELINES
• ABSTRACT TEMPLATE

Guidelines for abstract submission (free communications)

Free Communications are brief presentations (oral or poster) on studies, investigations, or observations in dermatology, and represent a vital component of the Scientific Program of the ICD. All Free Communications abstracts must be submitted online through the ICD Congress website. Select “Online Abstract Submission” and follow the steps making sure to carefully complete all sections. If all sections are not completed, your abstract submission will NOT be accepted.
The presenting author MUST REGISTER FOR THE ICD BY 3 MARCH, 2025 before the abstract can be officially be accepted for inclusion in the final scientific program and the official abstract book.

For additional information, please contact: icd2025abstract@thetriumph.com

Rules for abstract submission

a) Authors are required to indicate their preference for either ORAL or POSTER presentation by checking the appropriate box on the submission web page. The ICD Free Communications Committee will make the final decision on the format of presentation (i.e. oral or poster). Few selected posters will be scheduled for short oral presentations.

b) Acceptance or rejection of abstracts will be based on rankings given by a peer review of experts in the associated topic/category. Results of the selection process will be sent via e-mail to the corresponding author. The Committee decision is final and cannot be appealed.

c) Abstracts cannot be identical to any abstract that has previously been presented at a major international meeting prior to the ICD2025. An update to prior study is acceptable.

d) Instructions on the preparation of posters and information about projection facilities will be included with the notification of acceptance.

e) Submission of an abstract indicates: • that the author(s) agree to comply with the abstract submission and presentation rules; • that the presentation is based on scientific and/or clinical methods that are ethical and valid; • that all authors have contributed to and approve the abstract and its entire contents.

f) All accepted abstracts will be published electronically on digital media and on the ICD2025 website, and distributed to all delegates.

g) Accepted abstracts are official communications of the Congress. The presenting author agrees to register, to attend the Congress, and to present the abstract as scheduled by the ICD. The presenting author MUST REGISTER FOR THE ICD BY 3 MARCH, 2025 before the abstract can officially be accepted for inclusion in the final scientific program and official abstract book.

h) The evaluation and scoring of the abstract (acceptance as poster or as oral communication, or rejection) will be made according to a number of criteria, including: • Scholarly and/or research validity • Educational value • Clarity of presentation • Potential impact on global dermatology

Instructions for abstract preparation

(Please refer to the Abstract Template for specific guidance on formatting that will be available by February 2024).

a) Abstracts must be written and presented in English. Abstracts that are not written in understandable English will be rejected and/or returned to the author(s) for revision.

b) Abstract must be uploaded in WORD format (.doc; .docx)

c) Title, author’s names, author’s affiliation, presenting author must be provided by filling the online form • Title: Use a concise descriptive title that indicates the content of the abstract. Please minimize the use of abbreviations in the title. Commercial trade names for drugs, devices, products, and services may NOT be used in the title. • Author: The initial letter of the name(s) and the full surname for each author must be provided. Do not include degrees or titles. • Affiliations: Each author should be listed by department, institution, city, and country.

d) The body of the abstract text should not exceed 300 WORDS. The online submission program will automatically not allow submissions that do not fit this requirement. Symbols including superscripts and subscripts can be entered in the online system.

e) The body of the abstract text must be formatted with the following sub-headings as appropriate. Each sub-heading should be formatted in bold text, begin on a new line, and followed by a colon and space (:). The text for each sub-section should begin immediately after the colon and space (see sample abstract below). For clinical or investigative studies: • Introduction: • Objective: • Materials and Methods: • Results: • Conclusions: For case reports or case series: • Background: • Observation: • Key message: It is NOT satisfactory to simply state that “The results will be discussed.” Only common and standard abbreviations may be used without definition. NO REFERENCES, TABLES, CHARTS OR IMAGES ARE ALLOWED. Check spelling and grammar carefully. Direct reproduction from your electronically submitted abstract text means that any errors in spelling, grammar or scientific data will be reproduced as submitted. Drugs, devices, products, and services should be identified by generic name only within the abstract. The use of commercial drug names, brands and registered trademarks are strictly prohibited. No mention of pharmaceutical company names should be included in the abstract. Data must be given in units (International metric system is preferred) that are generally accepted in scientific publications. All co-authors must agree with the submitted results and conclusions, and consent to being listed as authors. Work involving humans or animals, or material derived from them must have been approved by an institutional ethics committee.

Abstract topics

1. Acne, Hidradenitis Suppurativa, Rosacea
2. Aesthetic & Cosmetic Dermatology
3. Artificial Intelligence & Skin Imaging
4. Atopic Dermatitis
5. Autoimmune Blistering Diseases
6. Climate Change
7. Contact Dermatitis
8. Cutaneous Adverse Reactions to Drugs
9. Cutaneous Oncology
10. Dermatologic Surgery
11. Dermatopathology
12. Dermoscopy
13. Gender Dermatology
14. Genodermatoses
15. Hair Disorders & Trichoscopy
16. Lasers
17. Medical Dermatology
18. Migrant Health
19. Mucosal Diseases
20. Nail Disorders
21. Novel Therapies
22. Pediatric Dermatology
23. Psychodermatology
24. Photobiology & Phototherapy
25. Physical Therapies (including PDT)
26. Pigmentary Disorders
27. Pruritus & Dysesthesias
28. Psoriasis
29. Sexually Transmitted Infections and HIV
30. Skin Aging: Extrinsic and Intrinsic Factors
31. Skin Infections & Tropical Diseases
32. Skin of Color
33. Teledermatology
34. Urticaria & Angioedema
35. Vasculitis & Vasculopathies
36. Wound Healing & Keloids
37. Miscellaneous
    Late-breaking abstracts

注册费：

The following rates include VAT and are quoted in Euros (EUR).

(1) – Members of the International Society of Dermatology (ISD).
(2) – Proof of status is necessary to finalise the registration.
(3) – Doctor undergoing a training program leading to specialisation in dermatology. The applicant’s age limit is 35 years at the time of the congress. Proof of status is required to complete registration.
(4) – Person residing in one of the countries defined by the World Bank as low-income or lower-middle income. For a complete and up-to-date list, please consult the World Bank website. A copy of your passport is required to complete the registration.

Registration Fee includes

Delegates

• Access to all Congress Sessions and Poster Area (Scientific Program sessions are open to registered delegates only)
• Access to Sponsored & Satellite Symposia
• Access to the Exhibition Area
• Welcome cocktail on 18 June 2025
• Opening and Closing Ceremonies

Courses Fees

Fees below are inclusive of any applicable taxes and quoted Euros (EUR).

Prescribers/Non-Prescribers

According to D.Lgs. 24 April 2006 n. 129 and ss. mm. and ii. the advertising of all types of medicines must be directed exclusively to persons able to prescribe or dispense them.

As the event will take place in Rome, Italy, and the XIV ICD Congress will be attended by a multidisciplinary audience, the Organizing Secretariat will assign different badges to Prescribers and Non-Prescribers to ensure compliance with the above regulations.

Access to the industry exhibition area will be restricted to Prescribers.

Nurses Non-Prescribers, Medical Students, will not be allowed into the exhibition area and will automatically be classified as NON-PRESCRIBERS.

Nurse Prescribers, Residents, ISD Members, Non-ISD Members and LI/LMI countries attendees will be allowed access to the exhibition area and will be classified as PRESCRIBERS.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。